Advertisement

Citation tools

Mikhael, Joseph et al "A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma." Blood 134.2 (2019): 123-133. Web. 18 July. 2019.